Energise RxS
- Manufacturer
- Deseret Biologicals | Apotheca Company
- Effective date
- 2022-08-30
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:54:46
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS:
Sarcolacticum Acidum 3X, Viscum Album 3X, Iodium 3X, 6X, 12X, 30X, Colchicum Autumnale 6X, Conium Maculatum 6X, Focus Vesiculosus 6X, Galium Aparine 6X, Natrum Oxalaceticum 6X, Thyroidinum (suis) 6X, 12X, 30X, Dehydro-Epi-Androsterone 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Phenyl Isothiocyanate 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Tri-Iodothronine 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Tyramine 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Alpha-Ketoglutaricum Acidum 7X, ATP 7X, Fumaricum Acidum 7X, Malic Acidum 7X, Funiculus Umbilicalis Suis 8X, 12X, 30X, Hepar Suis 8X, 12X, 30X, Medulls Ossis Suis 8X, 12X, 30X, Pineal Gland (suis) 8x, 12X, 30X, Spleen (suis) 8X, 12X, 30X, Thymus (suis) 8X, 12X, 30X, Calcarea Fluorica 12X, Pulsatilla 12X, Spongia Tosta 12X, Cortisone Aceticum 30X, Mercurius Corrosivus 60X, 100X, 200X, Gaertner Bach 30C, Mutabile Bach 30C
INDICATIONS:
For temporary relief of symptoms related to the thyroid system.
WARNINGS:
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
If pregnant or breast-feeding, ask a health professional before use.
Tamper seal: Sealed for your protection. Do not use if seal is broken or missing.
INACTIVE INGREDIENTS:
Lactose, Magnesium Stearate, Microcrystalline Cellulose.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
INDICATIONS:
For temporary relief of symptoms related to the thyroid system.
OTC - QUESTIONS SECTION
Dist. by Deseret Biologicals, Inc.
www.desbio.com
469 Parkland Drive, Sandy, UT 84070
PACKAGE LABEL
DESBIO
NDC 43742-0026-1
ENERGIZE RxS
HOMEOPATHIC SUPPORT
60 TABLETS
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43742-0026-1 | 2022-08-30 | C162847 | 48780-1 | 9d75b9d0-03bb-f424-e053-dadaa90a57ce | Drug Facts |
| 43742-0026-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03bb-f424-e053-dadaa90a57ce | Drug Facts |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .ALPHA.-KETOGLUTARIC ACID | ACTIVE INGREDIENT | 8ID597Z82X | 1 | |
| ADENOSINE TRIPHOSPHATE | ACTIVE INGREDIENT | 8L70Q75FXE | 1 | |
| CALCIUM FLUORIDE | ACTIVE INGREDIENT | O3B55K4YKI | 1 | |
| COLCHICUM AUTUMNALE BULB | ACTIVE INGREDIENT | 993QHL78E6 | 1 | |
| CONIUM MACULATUM FLOWERING TOP | ACTIVE INGREDIENT | Q28R5GF371 | 1 | |
| CORTISONE ACETATE | ACTIVE INGREDIENT | 883WKN7W8X | 1 | |
| ESCHERICHIA COLI | ACTIVE INGREDIENT | 514B9K0L10 | 1 | |
| FUCUS VESICULOSUS | ACTIVE INGREDIENT | 535G2ABX9M | 1 | |
| FUMARIC ACID | ACTIVE INGREDIENT | 88XHZ13131 | 1 | |
| GALIUM APARINE | ACTIVE INGREDIENT | Z4B6561488 | 1 | |
| IODINE | ACTIVE INGREDIENT | 9679TC07X4 | 1 | |
| LACTIC ACID, L- | ACTIVE INGREDIENT | F9S9FFU82N | 1 | |
| LIOTHYRONINE | ACTIVE INGREDIENT | 06LU7C9H1V | 1 | |
| MALIC ACID | ACTIVE INGREDIENT | 817L1N4CKP | 1 | |
| MERCURIC CHLORIDE | ACTIVE INGREDIENT | 53GH7MZT1R | 1 | |
| PHENYL ISOTHIOCYANATE | ACTIVE INGREDIENT | 0D58F84LSU | 1 | |
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 1 | |
| PRASTERONE | ACTIVE INGREDIENT | 459AG36T1B | 1 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS | ACTIVE INGREDIENT | Y3V16D4PV4 | 1 | |
| SODIUM DIETHYL OXALACETATE | ACTIVE INGREDIENT | 6CA025Y4FG | 1 | |
| SPONGIA OFFICINALIS SKELETON, ROASTED | ACTIVE INGREDIENT | 1PIP394IID | 1 | |
| SUS SCROFA BONE MARROW | ACTIVE INGREDIENT | VP2CN2G7Y8 | 1 | |
| SUS SCROFA PINEAL GLAND | ACTIVE INGREDIENT | 050QZ2EDK7 | 1 | |
| SUS SCROFA SPLEEN | ACTIVE INGREDIENT | 92AMN5J79Y | 1 | |
| SUS SCROFA THYMUS | ACTIVE INGREDIENT | 7B69B0BD62 | 1 | |
| SUS SCROFA UMBILICAL CORD | ACTIVE INGREDIENT | 118OYG6W3H | 1 | |
| THYROID, PORCINE | ACTIVE INGREDIENT | 6RV024OAUQ | 1 | |
| TYRAMINE | ACTIVE INGREDIENT | X8ZC7V0OX3 | 1 | |
| VISCUM ALBUM FRUITING TOP | ACTIVE INGREDIENT | BK9092J5MP | 1 | |
| .ALPHA.-KETOGLUTARIC ACID | ACTIVE MOIETY | 8ID597Z82X | 1 | |
| ADENOSINE TRIPHOSPHATE | ACTIVE MOIETY | 8L70Q75FXE | 1 | |
| COLCHICUM AUTUMNALE BULB | ACTIVE MOIETY | 993QHL78E6 | 1 | |
| CONIUM MACULATUM FLOWERING TOP | ACTIVE MOIETY | Q28R5GF371 | 1 | |
| CORTISONE | ACTIVE MOIETY | V27W9254FZ | 1 | |
| DIETHYL OXALACETATE | ACTIVE MOIETY | 15S56468G7 | 1 | |
| ESCHERICHIA COLI | ACTIVE MOIETY | 514B9K0L10 | 1 | |
| FLUORIDE ION | ACTIVE MOIETY | Q80VPU408O | 1 | |
| FUCUS VESICULOSUS | ACTIVE MOIETY | 535G2ABX9M | 1 | |
| FUMARIC ACID | ACTIVE MOIETY | 88XHZ13131 | 1 | |
| GALIUM APARINE | ACTIVE MOIETY | Z4B6561488 | 1 | |
| IODINE | ACTIVE MOIETY | 9679TC07X4 | 1 | |
| LACTIC ACID, L- | ACTIVE MOIETY | F9S9FFU82N | 1 | |
| LIOTHYRONINE | ACTIVE MOIETY | 06LU7C9H1V | 1 | |
| MALIC ACID | ACTIVE MOIETY | 817L1N4CKP | 1 | |
| MERCURIC CATION | ACTIVE MOIETY | ED30FJ8Y42 | 1 | |
| PHENYL ISOTHIOCYANATE | ACTIVE MOIETY | 0D58F84LSU | 1 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 1 | |
| PRASTERONE | ACTIVE MOIETY | 459AG36T1B | 1 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 1 | |
| SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS | ACTIVE MOIETY | Y3V16D4PV4 | 1 | |
| SPONGIA OFFICINALIS SKELETON, ROASTED | ACTIVE MOIETY | 1PIP394IID | 1 | |
| SUS SCROFA BONE MARROW | ACTIVE MOIETY | VP2CN2G7Y8 | 1 | |
| SUS SCROFA PINEAL GLAND | ACTIVE MOIETY | 050QZ2EDK7 | 1 | |
| SUS SCROFA SPLEEN | ACTIVE MOIETY | 92AMN5J79Y | 1 | |
| SUS SCROFA THYMUS | ACTIVE MOIETY | 7B69B0BD62 | 1 | |
| SUS SCROFA UMBILICAL CORD | ACTIVE MOIETY | 118OYG6W3H | 1 | |
| THYROID, PORCINE | ACTIVE MOIETY | 6RV024OAUQ | 1 | |
| TYRAMINE | ACTIVE MOIETY | X8ZC7V0OX3 | 1 | |
| VISCUM ALBUM FRUITING TOP | ACTIVE MOIETY | BK9092J5MP | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 |
Products#
Every source-derived product name is available through these pages.
- Energise RxS
- Sarcolacticum Acidum, Viscum Album, Iodium, Colchicum Atumnale, Conium Maculatum, Fucus Vesiculosus, Galiu Aparine, Natrum Oxalaceticum
- LACTIC ACID, L-
- VISCUM ALBUM FRUITING TOP
- IODINE
- COLCHICUM AUTUMNALE BULB
- CONIUM MACULATUM FLOWERING TOP
- FUCUS VESICULOSUS
- GALIUM APARINE
- SODIUM DIETHYL OXALACETATE
- DIETHYL OXALACETATE
- THYROID, PORCINE
- PRASTERONE
- PHENYL ISOTHIOCYANATE
- LIOTHYRONINE
- TYRAMINE
- .ALPHA.-KETOGLUTARIC ACID
- ADENOSINE TRIPHOSPHATE
- FUMARIC ACID
- MALIC ACID
- SUS SCROFA UMBILICAL CORD
- PORK LIVER
- SUS SCROFA BONE MARROW
- SUS SCROFA PINEAL GLAND
- SUS SCROFA SPLEEN
- SUS SCROFA THYMUS
- CALCIUM FLUORIDE
- FLUORIDE ION
- PULSATILLA VULGARIS
- SPONGIA OFFICINALIS SKELETON, ROASTED
- CORTISONE ACETATE
- CORTISONE
- MERCURIC CHLORIDE
- MERCURIC CATION
- SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS
- ESCHERICHIA COLI
- LACTOSE
- MAGNESIUM STEARATE
- CELLULOSE, MICROCRYSTALLINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 43742-0026 | 43742-0026-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE, FOR SUSPENSION / ORAL | 14 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | 315 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / ORAL | 420 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / BUCCAL | 296.7 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION / ORAL | 1600 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | 64 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | 4441 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / VAGINAL | 430 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 133 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / RECTAL | 8 %w/v | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION, EXTENDED RELEASE / ORAL | 1120 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | FILM, EXTENDED RELEASE / TRANSDERMAL | 675 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INSERT / VAGINAL | 69 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d8fc6dd7-d91d-4054-8632-a4819c4451f0 | 70c21d52-b73a-4d44-a08a-15b852d9307c | 2022-08-30 | Warnings | d8fc6dd7-d91d-4054-8632-a4819c4451f0 70c21d52-b73a-4d44-a08a-15b852d9307c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
